{"id":"W1956657204","doi":"10.1200/jco.2013.31.6_suppl.6","title":"Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Clinical endpoint; Placebo; Internal medicine; Docetaxel; Adverse effect; Concomitant; Abiraterone acetate; Oncology; Urology; Cancer; Randomized controlled trial; Androgen receptor; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003115676,0.0005005415,0.0009776871,0.000144794,0.0001901115,0.0008825786,0.0004755806,0.0007673125,0.002459243],"category_scores_gemma":[0.00286198,0.000232205,0.001446709,0.0001918794,0.0005557765,0.0005290665,0.0003831703,0.001502917,0.0003247527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005442639,"about_ca_system_score_gemma":0.0008487639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000570852,"about_ca_topic_score_gemma":0.002249407,"domain_scores_codex":[0.9987912,0.0008130965,0.00007243022,0.0001074916,0.00009340828,0.000122437],"domain_scores_gemma":[0.9970614,0.001040994,0.001014348,0.0001700274,0.0001182991,0.0005949638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9097629,0.00651635,0.02746447,0.0005812686,0.003906301,0.00009295004,0.0001023327,0.0007132745,0.004358804,0.0001043195,0.0009395172,0.04545751],"study_design_scores_gemma":[0.3138902,0.4927501,0.1737597,0.000168536,0.008955171,0.0003420001,0.0001738413,0.001710341,0.003860004,0.0004168395,0.003904073,0.00006918867],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995441,0.002932809,0.00006880306,0.0002342109,0.0000507275,0.0001366399,0.0003455251,0.000009878567,0.0007805213],"genre_scores_gemma":[0.9978015,0.0007923369,0.0001425694,0.0002683217,0.00006308731,0.00009162104,0.0003249156,0.000004898976,0.0005107347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003115676,"threshold_uncertainty_score":0.01647741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1868019128820495,"score_gpt":0.5268007643341991,"score_spread":0.3399988514521496,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}